Global Lipoprotein(a) Lowering Therapies Market Set for Robust Growth by 2032
The Lipoprotein(a) Lowering Therapies market is experiencing rapid growth as medical research continues to explore and develop innovative therapies targeting lipoprotein(a) [Lp(a)], a key factor in cardiovascular diseases. Lp(a) is a type of cholesterol that has long been associated with an increased risk of heart attacks, strokes, and other cardiovascular events. Recent breakthroughs in...
0 Yorumlar 0 hisse senetleri 658 Views 0 önizleme